Clin-e-cal Limited 09346983 false 2024-01-01 2024-12-31 2024-12-31 The principal activity of the company is the development and sale of software applications for medical and healthcare purposes Digita Accounts Production Advanced 6.30.9574.0 true 09346983 2024-01-01 2024-12-31 09346983 2024-12-31 09346983 bus:OrdinaryShareClass1 2024-12-31 09346983 bus:OrdinaryShareClass2 2024-12-31 09346983 core:CurrentFinancialInstruments 2024-12-31 09346983 core:CurrentFinancialInstruments core:WithinOneYear 2024-12-31 09346983 core:OtherResidualIntangibleAssets 2024-12-31 09346983 core:FurnitureFittingsToolsEquipment 2024-12-31 09346983 core:OtherPropertyPlantEquipment 2024-12-31 09346983 bus:SmallEntities 2024-01-01 2024-12-31 09346983 bus:AuditExemptWithAccountantsReport 2024-01-01 2024-12-31 09346983 bus:FilletedAccounts 2024-01-01 2024-12-31 09346983 bus:SmallCompaniesRegimeForAccounts 2024-01-01 2024-12-31 09346983 bus:RegisteredOffice 2024-01-01 2024-12-31 09346983 bus:Director1 2024-01-01 2024-12-31 09346983 bus:Director3 2024-01-01 2024-12-31 09346983 bus:OrdinaryShareClass1 2024-01-01 2024-12-31 09346983 bus:OrdinaryShareClass2 2024-01-01 2024-12-31 09346983 bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 09346983 bus:Agent1 2024-01-01 2024-12-31 09346983 core:IntangibleAssetsOtherThanGoodwill 2024-01-01 2024-12-31 09346983 core:OtherResidualIntangibleAssets 2024-01-01 2024-12-31 09346983 core:ComputerEquipment 2024-01-01 2024-12-31 09346983 core:FurnitureFittings 2024-01-01 2024-12-31 09346983 core:FurnitureFittingsToolsEquipment 2024-01-01 2024-12-31 09346983 core:OtherPropertyPlantEquipment 2024-01-01 2024-12-31 09346983 countries:AllCountries 2024-01-01 2024-12-31 09346983 2023-12-31 09346983 core:OtherResidualIntangibleAssets 2023-12-31 09346983 core:FurnitureFittingsToolsEquipment 2023-12-31 09346983 core:OtherPropertyPlantEquipment 2023-12-31 09346983 2023-01-01 2023-12-31 09346983 2023-12-31 09346983 bus:OrdinaryShareClass1 2023-12-31 09346983 bus:OrdinaryShareClass2 2023-12-31 09346983 core:CurrentFinancialInstruments 2023-12-31 09346983 core:CurrentFinancialInstruments core:WithinOneYear 2023-12-31 09346983 core:OtherResidualIntangibleAssets 2023-12-31 09346983 core:FurnitureFittingsToolsEquipment 2023-12-31 09346983 core:OtherPropertyPlantEquipment 2023-12-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 09346983

Clin-e-cal Limited

Unaudited Filleted Financial Statements

for the Year Ended 31 December 2024

 

Clin-e-cal Limited

Contents

Company Information

1

Directors' Report

2

Balance Sheet

3

Notes to the Unaudited Financial Statements

4 to 7

 

Clin-e-cal Limited

Company Information

Directors

T Aslam

MJ Sanders

Registered office

103 Gravel Lane
Wilmslow
Cheshire
SK9 6LZ

Bankers

Cooperative Bank

Accountants

McKellens Ltd
Chartered Accountants
11 Riverview
The Embankment Business Park
Vale Road
Heaton Mersey
Stockport
SK4 3GN

 

Clin-e-cal Limited

Directors' Report for the Year Ended 31 December 2024

The directors present their report and the financial statements for the year ended 31 December 2024.

Directors of the company

The directors who held office during the year were as follows:

T Aslam

MJ Sanders

Principal activity

The principal activity of the company is the development and sale of software applications for medical and healthcare purposes

Small companies provision statement

This report has been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

Approved by the Board on 4 July 2025 and signed on its behalf by:

.........................................
T Aslam
Director

   
     
 

Clin-e-cal Limited

(Registration number: 09346983)
Balance Sheet as at 31 December 2024

Note

2024
£

2023
£

Fixed assets

 

Intangible assets

4

71,977

79,175

Tangible assets

5

499

677

 

72,476

79,852

Current assets

 

Debtors

6

2,824

54,004

Cash at bank and in hand

 

11,704

66,080

 

14,528

120,084

Creditors: Amounts falling due within one year

7

(38,333)

(41,438)

Net current (liabilities)/assets

 

(23,805)

78,646

Net assets

 

48,671

158,498

Capital and reserves

 

Called up share capital

8

176

176

Share premium reserve

604,362

604,362

Retained earnings

(555,867)

(446,040)

Shareholders' funds

 

48,671

158,498

For the financial year ending 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 4 July 2025 and signed on its behalf by:
 

.........................................
T Aslam
Director

.........................................
MJ Sanders
Director

 
     
 

Clin-e-cal Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2024

1

General information

The company is a private company limited by share capital, incorporated in England & Wales.

The address of its registered office is:
103 Gravel Lane
Wilmslow
Cheshire
SK9 6LZ

These financial statements were authorised for issue by the Board on 4 July 2025.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Fixtures & Fittings

15% on a reducing balance basis

Computer equipment

33% on a reducing balance basis

 

Clin-e-cal Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2024

Amortisation

Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows:

Asset class

Amortisation method and rate

Intellectual property

over 18 years on a straight line basis

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 1 (2023 - 1).

 

Clin-e-cal Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2024

4

Intangible assets

Intellectual property
 £

Total
£

Cost or valuation

At 1 January 2024

129,559

129,559

At 31 December 2024

129,559

129,559

Amortisation

At 1 January 2024

50,384

50,384

Amortisation charge

7,198

7,198

At 31 December 2024

57,582

57,582

Carrying amount

At 31 December 2024

71,977

71,977

At 31 December 2023

79,175

79,175

5

Tangible assets

Fixtures & Fittings
 £

Computer equipment
£

Total
£

Cost or valuation

At 1 January 2024

655

2,842

3,497

At 31 December 2024

655

2,842

3,497

Depreciation

At 1 January 2024

424

2,396

2,820

Charge for the year

31

147

178

At 31 December 2024

455

2,543

2,998

Carrying amount

At 31 December 2024

200

299

499

At 31 December 2023

231

446

677

 

Clin-e-cal Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2024

6

Debtors

2024
£

2023
£

Prepayments

78

52,059

Other debtors

2,746

1,945

2,824

54,004

7

Creditors

Creditors: amounts falling due within one year

2024
£

2023
£

Due within one year

Trade creditors

77

149

Taxation and social security

-

2,320

Accruals and deferred income

1,727

2,427

Other creditors

36,529

36,542

38,333

41,438

8

Share capital

Allotted, called up and fully paid shares

 

2024

2023

 

No.

£

No.

£

Ordinary shares of £0.0001 each

1,319,888

131.99

1,319,888

131.99

A Ordinary shares of £0.0001 each

445,000

44.50

445,000

44.50

 

1,764,888

176

1,764,888

176